SIGA Technologies Inc. (SIGA): Price and Financial Metrics
SIGA Technologies Inc. (SIGA)
Today's Latest Price: $7.16 USD
Updated Jan 20 8:28pm
Add SIGA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SIGA Stock Summary
- For SIGA, its debt to operating expenses ratio is greater than that reported by just 0.52% of US equities we're observing.
- With a year-over-year growth in debt of -100%, Siga Technologies Inc's debt growth rate surpasses merely 0% of about US stocks.
- As for revenue growth, note that SIGA's revenue has grown 280.47% over the past 12 months; that beats the revenue growth of 97.57% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Siga Technologies Inc are VSTM, VREX, WISA, VECO, and SQNS.
- SIGA's SEC filings can be seen here. And to visit Siga Technologies Inc's official web site, go to www.siga.com.
SIGA Stock Price Chart Interactive Chart >
SIGA Price/Volume Stats
| Current price | $7.16 | 52-week high | $8.10 |
| Prev. close | $7.19 | 52-week low | $3.96 |
| Day low | $7.07 | Volume | 199,200 |
| Day high | $7.21 | Avg. volume | 179,800 |
| 50-day MA | $7.27 | Dividend yield | N/A |
| 200-day MA | $6.60 | Market Cap | 554.18M |
SIGA Technologies Inc. (SIGA) Company Bio
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.
SIGA Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $7.16 | $0.59 | -92% |
Below please find a table outlining a discounted cash flow forecast for SIGA, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Siga Technologies Inc ranked in the 11th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Siga Technologies Inc, consider:
- The company's compound free cash flow growth rate over the past 5.26 years comes in at -0.1%; that's greater than merely 13.91% of US stocks we're applying DCF forecasting to.
- As a business, SIGA is generating more cash flow than merely 16.43% of positive cash flow stocks in the Healthcare.
- The business' balance sheet reveals debt to be 0% of the company's capital (with equity being the remaining amount). Approximately only 0.05% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -92% |
| 1% | -92% |
| 2% | -92% |
| 3% | -92% |
| 4% | -92% |
| 5% | -91% |
BHC, EW, QGEN, SRDX, and COO can be thought of as valuation peers to SIGA, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...